SLC2A3 and Alzheimer disease: In 1993, Simpson and colleagues reported that in the brains of patients with AD, the amount of GLUT1 and GLUT3 was reduced in some regions, including the hippocampus; the reduction was larger for GLUT3, and was accompanied by a significant loss of synapses [133].